Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Fluence Energy
FLNC
$1.75B
| $453K | ﹤0.01% |
26,400
-96,600
| -79% | -$1.52M |
|
3002
Denison Mines
DNN
$2.83B
| $452K | ﹤0.01% |
+393,513
| New | +$466K |
|
|
CONN
3003
DELISTED
Conn's Inc.
CONN
| $452K | ﹤0.01% |
+65,654
| New | +$518K |
|
3004
Astronics
ATRO
$3.75B
| $450K | ﹤0.01% |
52,440
+240
| +0.5% | +$1.77K |
|
3005
Ingredion
INGR
$6.49B
| $450K | ﹤0.01% |
4,600
-7,000
| -60% | -$646K |
|
3006
Mission Produce
AVO
$1.11B
| $449K | ﹤0.01% |
38,600
+7,500
| +24% | +$115K |
|
3007
Electromed
ELMD
$348M
| $449K | ﹤0.01% |
42,804
-5,100
| -11% | -$51.9K |
|
|
MKFG
3008
DELISTED
Markforged Holding Corporation
MKFG
| $449K | ﹤0.01% |
38,744
+7,261
| +23% | +$111K |
|
3009
Amcor
AMCR
$21.8B
| $448K | ﹤0.01% |
7,520
+4,680
| +165% | +$273K |
|
3010
Capital Bancorp
CBNK
$616M
| $447K | ﹤0.01% |
19,002
-13,998
| -42% | -$338K |
|
3011
Dimensional World ex US Core Equity 2 ETF
DFAX
$12.3B
| $447K | ﹤0.01% |
20,700
-69,900
| -77% | -$1.45M |
|
3012
Atossa Therapeutics
ATOS
$24.1M
| $446K | ﹤0.01% |
56,318
-16,729
| -23% | -$192K |
|
|
ZYNE
3013
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $445K | ﹤0.01% |
840,500
-269,535
| -24% | -$171K |
|
3014
Perma-Fix Environmental Services
PESI
$377M
| $443K | ﹤0.01% |
125,496
+9,133
| +8% | +$35.1K |
|
3015
Vanguard Materials ETF
VAW
$3.08B
| $443K | ﹤0.01% |
2,600
+900
| +53% | +$151K |
|
3016
Veru
VERU
$37.1M
| $443K | ﹤0.01% |
8,394
-32,320
| -79% | -$2.66M |
|
3017
Scully Royalty
SRL
$86.5M
| $442K | ﹤0.01% |
57,314
-5,800
| -9% | -$45.1K |
|
3018
Celcuity
CELC
$4.55B
| $441K | ﹤0.01% |
31,456
-25,100
| -44% | -$257K |
|
3019
FormFactor
FORM
$9B
| $440K | ﹤0.01% |
19,788
-44,080
| -69% | -$1.03M |
|
|
TCS
3020
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $439K | ﹤0.01% |
6,787
-16,626
| -71% | -$1.2M |
|
3021
Fidelity D&D Bancorp
FDBC
$313M
| $438K | ﹤0.01% |
9,300
-1,490
| -14% | -$68.1K |
|
3022
Grupo Cibest SA
CIB
$21.4B
| $437K | ﹤0.01% |
+15,300
| New | +$395K |
|
3023
UNIFI
UFI
$128M
| $437K | ﹤0.01% |
50,734
-12,400
| -20% | -$107K |
|
3024
iShares Agency Bond ETF
AGZ
$564M
| $436K | ﹤0.01% |
+4,100
| New | +$436K |
|
|
ACHL
3025
DELISTED
Achilles Therapeutics
ACHL
| $436K | ﹤0.01% |
484,733
+403,700
| +498% | +$680K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.